MTOR and diffuse large B-cell lymphoma: We confirmed that also the expression of mTOR protein was increased in 128 DLBCL samples compared with 20 lymph node controls (TMA sections) (histoscore: 5.7 ± 0.9 vs 4.0 ± 0.8, p =0.05; mTOR+ cells: 64.3% ± 14.2 vs 32.6% ± 4.9, p =0.04).